Davenport & Co’s Zai Lab ZLAB Stock Holding History

Davenport & Co’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,137	Closed	-$201K	–	1054
2021 Q2	$201K	Buy	+1,137	New	+$183K	﹤0.01%	905

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Davenport & Co's ZLAB Position: Q3 2021 in Review

Davenport & Co sold out of Zai Lab (ZLAB) in Q3 2021, closing a stake of 1,137 shares — an estimated $201K sold.

Davenport & Co first reported a position in ZLAB in Q2 2021 and held it in 1 quarter. The position peaked at $201K in Q2 2021. 227 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

Davenport & Co reported no remaining Zai Lab position as of Q3 2021 after selling out during the quarter.
Davenport & Co sold 1,137 Zai Lab shares in Q3 2021, an estimated $201K.
Davenport & Co first reported a position in Zai Lab in Q2 2021 and held it in 1 quarter.
Davenport & Co's Zai Lab position peaked at $201K in Q2 2021.
227 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Davenport & Co's 13F filing for Q3 2021, filed 14 Oct 2021.